top of page
Rinnit logo – modern health products and health news

Autoimmune Pancreatitis: Symptoms, Types, Causes, Diagnosis & Treatment — Complete Guide

Oct 12
11 min read

Updated: 3 days ago

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026

Quick Answer: What Is Autoimmune Pancreatitis?

Autoimmune pancreatitis (AIP) is inflammation of the pancreas caused by the immune system mistakenly attacking it. Type 1 often affects several organs and mostly strikes older men, while type 2 affects only the pancreas. Its most distinctive sign is painless jaundice. It responds remarkably well to steroids but must be distinguished from pancreatic cancer, which looks similar.

What the research says

  • Steroids bring almost everyone into remission, but type 1 relapses far more often than type 2. In an international analysis of 1,064 patients (978 type 1, 86 type 2) from 23 institutions in 10 countries, 99% of treated type 1 and 92% of treated type 2 patients went into clinical remission on steroids, while relapses occurred in 31% of type 1 versus 9% of type 2 patients — and in 56% versus 26% for those with IgG4-related sclerosing cholangitis. (Hart et al., Gut, 2013) [3]

  • Type 2 AIP often travels with inflammatory bowel disease. In 91 people with both AIP and IBD from 23 centers in Belgium and France, 89 had type 2 AIP and only 2 had type 1; over a mean follow-up of 5.7 years, 34% relapsed, 12% developed diabetes and 19% developed exocrine pancreatic insufficiency. (Lorenzo et al., Clin Gastroenterol Hepatol, 2018) [4]

  • Maintenance treatment is often needed because of relapse. Among 52 Spanish patients who met international criteria (45 with type 1), initial treatment succeeded with steroids in 79.8% and with surgery in 17.3%; maintenance treatment was given to 59.6%, relapses occurred in 40.4% of type 1 patients, and long-term remission was reached in 86.4%. (López-Serrano et al., Pancreatology, 2016) [5]

Autoimmune Pancreatitis at a Glance

Aspect

Key Facts

Also known as

AIP; type 1 = IgG4-related disease (IgG4-RD)

What happens

The immune system attacks the pancreas, causing inflammation

Most common sign

Painless jaundice (yellow skin and eyes) — about 80% of type 1 cases

Who it affects

Type 1: mostly men over 60; Type 2: men and women equally, younger

How it's diagnosed

Imaging + IgG4 blood test + biopsy + sometimes steroid trial

First-line treatment

Steroids (prednisone or prednisolone) — often dramatic improvement

Relapse risk

Type 1: 30–50%; Type 2: under 10%

Outlook

Typical life expectancy with treatment

What Is Autoimmune Pancreatitis?

Autoimmune pancreatitis is an inflammation in the pancreas — the gland behind your stomach that makes digestive enzymes and insulin. In AIP, the immune system mistakenly attacks healthy pancreatic tissue. Experts consider it an autoimmune disease, meaning the body's own defenses turn against itself.

What makes AIP tricky is that it can look very similar to pancreatic cancer. The two conditions share overlapping symptoms, but their treatments are completely different — which is why getting an accurate diagnosis matters enormously.

Experts recognize two subtypes of AIP:

  • Type 1 AIP (IgG4-related disease, or IgG4-RD): often affects multiple organs — the pancreas, the bile ducts in the liver, the salivary glands, the kidneys, and lymph nodes.

  • Type 2 AIP: seems to affect only the pancreas, although about one-third of people with type 2 also have inflammatory bowel disease.

Type 1 vs. type 2 autoimmune pancreatitis comparison — organs affected, who it strikes, IgG4 levels, and relapse rates – rinnit.com
Diagram: Type 1 AIP (IgG4-related disease) often involves the liver bile ducts, salivary glands, kidneys, and lymph nodes, while type 2 affects only the pancreas — and the two differ in age, sex, and relapse risk. Image courtesy of rinnit.com.

What are the symptoms of autoimmune pancreatitis?

AIP is difficult to diagnose partly because it often causes no symptoms at all. When symptoms do appear, type 1 AIP tends to look like pancreatic cancer.

The shared symptom list includes:

  • Dark urine

  • Pale stools, or stools that float in the toilet

  • Jaundice — yellow skin and eyes

  • Pain in the upper belly or the middle part of your back

  • Nausea and vomiting

  • Weakness or extreme tiredness

  • Loss of appetite, or feelings of fullness

  • Unexplained weight loss

The signature sign: painless jaundice

The most common sign of type 1 AIP is painless jaundice — yellowing of the skin and eyes without significant belly pain. About 80% of people with type 1 AIP have it. The yellowing happens because blocked bile ducts prevent bile from draining normally.

The reverse pattern is equally telling: upper-abdomen pain, one of the classic symptoms of pancreatic cancer, is often absent in autoimmune pancreatitis. That difference is one clue doctors use to tell the two conditions apart.

Type 2 pattern: repeat attacks

People with type 2 AIP can have repeat episodes of acute pancreatitis — sudden, painful attacks of pancreatic inflammation that come and go.

How the two types differ

Feature

Type 1 AIP

Type 2 AIP

Other organs affected

Yes — bile ducts, salivary glands, kidneys, lymph nodes

Only the pancreas

Associated conditions

IgG4-related disease pattern

Inflammatory bowel disease in about 1 in 3 people

Who it affects

Mostly men in their 60s–70s

Men and women equally, at a younger age

Relapse after treatment

More likely to return

Less likely to return

When to see a doctor

Because AIP often causes no symptoms, you may never feel anything is wrong. See a healthcare professional, however, if you experience unexplained weight loss, belly pain, jaundice, or other symptoms that bother you.

What causes autoimmune pancreatitis and who is at risk?

The exact cause of autoimmune pancreatitis (AIP) is unknown, but it is thought to result from the immune system attacking healthy tissue, and risk factors differ between its two types.

Causes

Experts don't know exactly what causes autoimmune pancreatitis, but it is thought to result from the body's immune system attacking healthy body tissue — the hallmark of an autoimmune disease.

Risk factors

The two types of AIP show up differently around the world. In the United States, about 80% of people with AIP have type 1.

People with type 1 AIP often:

  • Are over age 60

  • Are male

People with type 2 AIP:

  • Are often one or two decades younger than those with type 1

  • Are as likely to be female as male

  • Are more likely to have inflammatory bowel disease, such as ulcerative colitis

What are the complications of autoimmune pancreatitis?

Autoimmune pancreatitis can cause complications such as pancreatic exocrine insufficiency, diabetes and duct narrowing, and treatment itself can add others. The main ones to understand:

  • Pancreatic exocrine insufficiency: AIP may impair the pancreas's ability to make enough digestive enzymes. Symptoms can include diarrhea, weight loss, metabolic bone disease, and vitamin or mineral deficiencies.

  • Diabetes: The pancreas produces insulin, so damage to it may cause diabetes. You may need treatment with oral medicine or insulin.

  • Stricture: narrowing of the pancreatic ducts and bile ducts.

  • Pancreatic calcifications or stones.

Long-term steroid use can also cause complications. The good news: even with these complications, people who are treated for autoimmune pancreatitis generally have a typical life expectancy. And reassuringly, there is no established association between AIP and pancreatic cancer.

How is autoimmune pancreatitis diagnosed and told apart from pancreatic cancer?

Autoimmune pancreatitis is hard to diagnose because its symptoms resemble pancreatic cancer. Getting it right is critical — undiagnosed cancer can mean delaying or missing necessary treatment, while misdiagnosing AIP as cancer can lead to unnecessary surgery.

People with AIP tend to have a general enlargement of the pancreas, though a mass may also appear. No single test identifies AIP, so doctors rely on a combination of imaging, blood tests, and biopsy results.

The diagnostic tests

Test

What It Shows

Notes

CT scan

Pancreas shape, size, and masses

Part of the core imaging set

MRI

Detailed soft-tissue pictures of pancreas and ducts

Part of the core imaging set

Endoscopic ultrasound (EUS)

High-detail views from inside the digestive tract

Part of the core imaging set

ERCP

Images of the bile and pancreatic ducts

Part of the core imaging set

IgG4 blood test

Elevated IgG4 immunoglobulin levels

High in type 1, usually not in type 2 — but not definitive

Endoscopic core biopsy

Distinctive tissue appearance under the microscope

Needs a large enough sample; not widely available

Steroid trial

Rapid improvement confirms the autoimmune pattern

Only under expert guidance, with strong supporting evidence

The IgG4 blood test deserves a closer look. People with type 1 AIP often have high levels of IgG4 (an immunoglobulin produced by the immune system), while people with type 2 usually do not. But a positive test doesn't automatically mean AIP — some people without the disease, including some with pancreatic cancer, also have elevated IgG4.

The endoscopic core biopsy involves passing an endoscope through the mouth into the stomach, guided by ultrasound, then using a special needle to remove a tissue sample. A pathologist studies it under the microscope, and AIP has a distinctive appearance experts can recognize. The challenge is getting a sample large enough to study — and the procedure isn't widely available, so results may not be conclusive.

Finally, a steroid trial may be used to confirm the diagnosis. AIP generally responds to steroids, so a supervised short course — with response measured by CT scans and falling IgG4 levels — can help confirm the diagnosis. This strategy should be used sparingly and only when there is strong evidence pointing to AIP.

How is autoimmune pancreatitis treated?

Steroids are the cornerstone treatment for autoimmune pancreatitis, sometimes preceded by biliary stenting and followed by immunosuppressants if the disease relapses.

Biliary stenting

Before starting medicine, doctors may insert a tube to drain the biliary ducts — a procedure called biliary stenting — for people with symptoms of obstructive jaundice. Often, though, jaundice improves with steroid treatment alone. Drainage is sometimes recommended when the diagnosis isn't certain, and tissue samples can be taken from the bile duct at the time of stent placement.

Steroids — the cornerstone treatment

Symptoms of autoimmune pancreatitis often improve after a short course of prednisolone or prednisone. Many people respond quickly, even dramatically — and some people get better without any treatment at all.

Immunosuppressants and immunomodulators

The disease can relapse. For type 1 AIP, relapse happens about 30% to 50% of the time; for type 2, less than 10%. Relapses require additional treatment, sometimes long term.

To reduce the serious side effects of extended steroid use, doctors may add steroid-sparing medicines that suppress or modify the immune system. Depending on how you respond, you may be able to stop taking steroids altogether.

Medicine

Brand Names

Role

Mycophenolate

CellCept

Immunosuppressant / steroid-sparing

Mercaptopurine

Purinethol, Purixan

Immunosuppressant / steroid-sparing

Azathioprine

Imuran, Azasan

Immunosuppressant / steroid-sparing

Rituximab

Rituxan

Immunomodulator / steroid-sparing

These medicines have generally been studied in small sample groups so far, and their long-term benefits are still being researched.

Monitoring other organs

Because type 1 AIP is often associated with other organ involvement, your care team will continue to watch for:

  • Enlarged lymph nodes and salivary glands

  • Scarring of the bile ducts

  • Liver inflammation

  • Kidney disease

These signs may lessen or disappear completely with steroid therapy, but monitoring continues. Clinical trials are also exploring new treatments, interventions, and tests.

Autoimmune pancreatitis complete patient guide infographic: symptoms, the two types, diagnosis pathway, treatment ladder, complications and when to see a doctor – rinnit.com
Infographic: The complete patient guide to autoimmune pancreatitis — symptoms, the two types, how it is diagnosed, the treatment ladder from stenting to steroids, and when to see a doctor. Image courtesy of rinnit.com.

How should you prepare for an autoimmune pancreatitis appointment?

If your care team suspects autoimmune pancreatitis, you may be referred to a gastroenterologist (digestive system specialist) or a pancreatologist (pancreas specialist).

What you can do — 6 steps

  1. Ask about pre-appointment restrictions, such as diet limits.

  2. Write down your symptoms, including any that seem unrelated.

  3. Note key personal information, including major stresses or recent life changes.

  4. List all medications, vitamins, and supplements.

  5. Consider bringing a family member or friend to help remember the details.

  6. Write down your questions in advance.

Questions to ask your doctor

  • Can you explain my test results to me?

  • How can you be sure I do not have pancreatic cancer?

  • Will I need more tests?

  • How far has my disease progressed?

  • Will it come back after initial treatment?

  • Do I need lifelong treatment to prevent relapse?

  • What do I need to do if it comes back?

  • How severe is the damage to my pancreas?

  • What treatments can relieve symptoms?

  • What are the potential side effects of each treatment?

  • What symptoms signal my condition is worsening?

  • What complication symptoms should I watch for?

  • I have other health conditions — how can I best manage them together?

  • Are there restrictions I need to follow?

  • Are there brochures or recommended websites I can take with me?

What to expect from your doctor

Be ready to answer questions such as:

  • When did your symptoms begin?

  • Do you have abdominal pain, dark urine, pale stools, itching, or weight loss?

  • Are your symptoms continuous or occasional?

  • How severe are they?

  • What seems to improve or worsen them?

  • Have you had these symptoms before?

  • Have you ever been diagnosed with pancreatitis?

  • Did you start any new medicines before your symptoms began?

Frequently Asked Questions

What is autoimmune pancreatitis?

Autoimmune pancreatitis (AIP) is inflammation of the pancreas caused by the body's immune system mistakenly attacking the organ. It is a form of autoimmune disease, and experts recognize two subtypes: type 1 (IgG4-related disease) and type 2.

Is autoimmune pancreatitis the same as pancreatic cancer?

No — but they can look very similar, which is why accurate diagnosis is critical. The two conditions share overlapping symptoms such as jaundice and weight loss, yet their treatments are completely different, and there is no established association between AIP and pancreatic cancer.

What is the most common sign of autoimmune pancreatitis?

The most common sign of type 1 AIP is painless jaundice — yellowing of the skin and eyes without significant belly pain — seen in about 80% of people with the condition. It is caused by blocked bile ducts.

How is autoimmune pancreatitis diagnosed?

No single test confirms it, so doctors combine imaging (CT, MRI, endoscopic ultrasound, ERCP), an IgG4 blood test, an endoscopic core biopsy, and sometimes a carefully supervised steroid trial. High IgG4 levels suggest type 1 but are not definitive on their own.

Does autoimmune pancreatitis respond to treatment?

Yes — symptoms often improve quickly, sometimes dramatically, after a short course of steroids such as prednisone or prednisolone. Some people even improve without any treatment at all.

Can autoimmune pancreatitis come back?

Yes, relapse is possible: about 30–50% of type 1 cases relapse, while fewer than 10% of type 2 cases do. Steroid-sparing medicines such as azathioprine, mycophenolate, mercaptopurine, or rituximab help reduce the need for long-term steroids.

What is the outlook for autoimmune pancreatitis?

The outlook is encouraging. Even with complications from the disease or from long-term steroid treatment, people who are treated for autoimmune pancreatitis generally have a typical life expectancy.

Conclusion: What to Remember About Autoimmune Pancreatitis

Three lessons stand out from this guide:

  • AIP mimics pancreatic cancer — but isn't cancer. Painless jaundice in an older man, without the belly pain typical of cancer, is a classic AIP pattern. Accurate diagnosis protects you from both missed cancer and unnecessary surgery.

  • Steroids are the turning point. Most people respond quickly and dramatically to a short course of prednisone or prednisolone — and some improve on their own.

  • Stay watchful for relapse, especially with type 1. With monitoring, steroid-sparing medicines, and follow-up care, people with treated AIP typically live out a normal life expectancy.

This guide has walked you through what autoimmune pancreatitis is, its two types, the signs to watch for, how doctors tell it apart from cancer, and the treatment ladder from stenting to steroids. If you or a loved one are managing a digestive or autoimmune condition, explore more in-depth health guides in the library at rinnit.com. From the asthma complete guide — covering a different immune-driven condition — to the full rinnit.com library, detailed health information is always one click away.

Was this guide helpful? Leave a comment below and tell us what you'd like us to cover next.

This article is for informational purposes only and is not a substitute for professional medical advice. Seek care for jaundice, unexplained weight loss, belly pain, or symptoms that worry you.

References

  1. Mayo Clinic Staff. Autoimmune pancreatitis — Symptoms and causes. Mayo Clinic. December 16, 2023. https://www.mayoclinic.org/diseases-conditions/autoimmune-pancreatitis/symptoms-causes/syc-20369800

  2. Mayo Clinic Staff. Autoimmune pancreatitis — Diagnosis and treatment. Mayo Clinic. December 16, 2023. https://www.mayoclinic.org/diseases-conditions/autoimmune-pancreatitis/diagnosis-treatment/drc-20369804

  3. Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62(12):1771-1776. PMID 23232048. https://doi.org/10.1136/gutjnl-2012-303617

  4. Lorenzo D, Maire F, Stefanescu C, et al. Features of autoimmune pancreatitis associated with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2018;16(1):59-67. PMID 28782667. https://doi.org/10.1016/j.cgh.2017.07.033

  5. López-Serrano A, Crespo J, Pascual I, et al. Diagnosis, treatment and long-term outcomes of autoimmune pancreatitis in Spain based on the International Consensus Diagnostic Criteria: a multi-centre study. Pancreatology. 2016;16(3):382-390. PMID 26944001. https://doi.org/10.1016/j.pan.2016.02.006

Comments


bottom of page